UB Paderborn / Katalog / Suche / in CDI

Maintenance therapy with hypomethylating agents for patients with acute myeloid leukemia in first remission not eligible for allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis

Leukemia research, 2022-02, Vol.113, p.106773-106773, Article 106773

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of FLAG-Ida-based therapy combined with venetoclax for the treatment for newly diagnosed and relapsed/refractory patients with AML – A systematic review

Leukemia research, 2023-10, Vol.133, p.107368-107368, Article 107368

2023

Link zum Volltext

Verfügbarkeit prüfen

Enteroviral infection in patients treated with rituximab for non‐Hodgkin lymphoma: a case series and review of the literature

Hematological oncology, 2017-12, Vol.35 (4), p.591-598

2017

Link zum Volltext

Verfügbarkeit prüfen

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study

Clinical microbiology and infection, 2018-07, Vol.24 (7), p.749-754

2018

Link zum Volltext

Verfügbarkeit prüfen

Prophylaxis regimens for GVHD: systematic review and meta-analysis

Bone marrow transplantation (Basingstoke), 2009-04, Vol.43 (8), p.643-653

2009

Link zum Volltext

Verfügbarkeit prüfen

P1461: CAR‐T VS. STANDARD OF CARE AS SECOND LINE TREATMENT FOR LARGE B CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META‐ANALYSIS

HemaSphere, 2022-06, Vol.6 (Suppl), p.1343-1344

2022

Link zum Volltext

Verfügbarkeit prüfen

Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?

Annals of oncology, 2006-01, Vol.17 (1), p.117-122

2006

Link zum Volltext

Verfügbarkeit prüfen

R‐CHOP VS. R‐CHOP+X FOR NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META‐ANALYSIS

Hematological oncology, 2019-06, Vol.37 (S2), p.424-424

2019

Link zum Volltext

Verfügbarkeit prüfen

P1166: REPEAT BIOPSY IN RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A NATIONWIDE SURVEY AND RETROSPECTIVE STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1053-1054

2022

Link zum Volltext

Verfügbarkeit prüfen

Extramedullary disease and targeted therapies for hematological malignancies—is the association real?

Annals of oncology, 2007-01, Vol.18 (1), p.7-12

2007

Link zum Volltext

Verfügbarkeit prüfen

PREVALENCE AND CLINICAL SIGNIFICANCE OF HYPERCALCEMIA AT DIAGNOSIS IN DIFFUSE LARGE B CELL LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.420-421

2019

Link zum Volltext

Verfügbarkeit prüfen

P979: EXOSOMES IN POLYCYTHEMIA VERA: “MINI PLATELETS“ WITH THROMBOGENIC POTENTIAL

HemaSphere, 2022-06, Vol.6 (Suppl), p.869-870

2022

Link zum Volltext

Verfügbarkeit prüfen

Does Bone Marrow Cellularity (BMC) Have a Role in Predicting Prognosis and Survival in Myelodysplastic Syndromes (MDS)?

Leukemia research, 2017-04, Vol.55, p.S142-S142

2017

Link zum Volltext

Verfügbarkeit prüfen

P578: GILTERITINIB FOR RELAPSED/REFRACTORY FLT3 MUTATED ACUTE MYELOID LEUKEMIA A REAL‐WORLD, MULTI‐CENTER, MATCHED ANALYSIS

HemaSphere, 2022-06, Vol.6, p.477-478

2022

Link zum Volltext

Verfügbarkeit prüfen

P585: VENETOCLAX IN COMBINATION WITH INTENSIVE TREATMENT PROTOCOLS FOR PATIENTS WITH HIGH‐RISK ACUTE MYELOID LEUKEMIA – A MULTICENTER REAL‐WORLD ANALYSIS

HemaSphere, 2022-06, Vol.6, p.484-485

2022

Link zum Volltext

Verfügbarkeit prüfen

PET‐CT–adapted therapy for advanced Hodgkin lymphoma: A systematic review of the literature

Hematological oncology, 2017-06, Vol.35 (S2), p.300-301

2017

Link zum Volltext

Verfügbarkeit prüfen

The role of maintenance therapy in patients with diffuse large B‐cell lymphoma: A systematic review and meta‐analysis

Hematological oncology, 2017-06, Vol.35 (S2), p.338-339

2017

Link zum Volltext

Verfügbarkeit prüfen

THE VALUE OF PET/CT IN DETECTING BONE MARROW INVOLVEMENT IN PATIENTS WITH PERIPHERAL T‐CELL LYMPHOMA

Hematological oncology, 2017-06, Vol.35 (S2), p.392-393

2017

Link zum Volltext

Verfügbarkeit prüfen

P1203: THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION

HemaSphere, 2022-06, Vol.6 (Suppl), p.1089-1090

2022

Link zum Volltext

Verfügbarkeit prüfen

C0431: High Incidence of Thrombotic Cerebral Lesions in Adult Patients with Beta-Thalassemia Major

Thrombosis research, 2014-05, Vol.133, p.S116-S116

2014

Link zum Volltext

Verfügbarkeit prüfen

P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS

HemaSphere, 2022-06, Vol.6 (Suppl), p.1465-1466

2022

Link zum Volltext

Verfügbarkeit prüfen

105 HIGH RESPONSE RATE FOR AZACITIDINE-LENALIDOMIDE (VI-LEN) COMBINATION IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS) - VILEN-01 PROTOCOL UPDATE

Leukemia research, 2015-04, Vol.39, p.S54-S54

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapy with thalidomide in refractory multiple myeloma patients — the revival of an old drug

British journal of haematology, 2000-02, Vol.108 (2), p.391-393

2000

Link zum Volltext

Verfügbarkeit prüfen

Graft-versus-leukemia in chronic lymphocytic leukemia

Bone marrow transplantation (Basingstoke), 2007-04, Vol.39 (8), p.441-446

2007

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

Haematologica (Roma), 2016-09, Vol.101 (9), p.1065

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Maintenance therapy with hypomethylating agents for patients with acute myeloid leukemia in first remission not eligible for allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis

Safety and efficacy of FLAG-Ida-based therapy combined with venetoclax for the treatment for newly diagnosed and relapsed/refractory patients with AML – A systematic review

Enteroviral infection in patients treated with rituximab for non‐Hodgkin lymphoma: a case series and review of the literature

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study

Prophylaxis regimens for GVHD: systematic review and meta-analysis

P1461: CAR‐T VS. STANDARD OF CARE AS SECOND LINE TREATMENT FOR LARGE B CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META‐ANALYSIS

Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?

R‐CHOP VS. R‐CHOP+X FOR NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META‐ANALYSIS

P1166: REPEAT BIOPSY IN RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A NATIONWIDE SURVEY AND RETROSPECTIVE STUDY

Extramedullary disease and targeted therapies for hematological malignancies—is the association real?

PREVALENCE AND CLINICAL SIGNIFICANCE OF HYPERCALCEMIA AT DIAGNOSIS IN DIFFUSE LARGE B CELL LYMPHOMA

P979: EXOSOMES IN POLYCYTHEMIA VERA: “MINI PLATELETS“ WITH THROMBOGENIC POTENTIAL

Does Bone Marrow Cellularity (BMC) Have a Role in Predicting Prognosis and Survival in Myelodysplastic Syndromes (MDS)?

P578: GILTERITINIB FOR RELAPSED/REFRACTORY FLT3 MUTATED ACUTE MYELOID LEUKEMIA A REAL‐WORLD, MULTI‐CENTER, MATCHED ANALYSIS

P585: VENETOCLAX IN COMBINATION WITH INTENSIVE TREATMENT PROTOCOLS FOR PATIENTS WITH HIGH‐RISK ACUTE MYELOID LEUKEMIA – A MULTICENTER REAL‐WORLD ANALYSIS

PET‐CT–adapted therapy for advanced Hodgkin lymphoma: A systematic review of the literature

The role of maintenance therapy in patients with diffuse large B‐cell lymphoma: A systematic review and meta‐analysis

THE VALUE OF PET/CT IN DETECTING BONE MARROW INVOLVEMENT IN PATIENTS WITH PERIPHERAL T‐CELL LYMPHOMA

P1203: THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION

C0431: High Incidence of Thrombotic Cerebral Lesions in Adult Patients with Beta-Thalassemia Major

P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS

105 HIGH RESPONSE RATE FOR AZACITIDINE-LENALIDOMIDE (VI-LEN) COMBINATION IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS) - VILEN-01 PROTOCOL UPDATE

Therapy with thalidomide in refractory multiple myeloma patients — the revival of an old drug

Graft-versus-leukemia in chronic lymphocytic leukemia

Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

Suchergebnisse filtern